Analyst
Jefferies
Equibles does not estimate personal net worth.
Stephen Barker is recorded as Analyst at Jefferies. Stephen Barker has spoken on 2 earnings calls across 1 company, most recently for Takeda Pharmaceutical Co Ltd on October 29, 2026. The companies whose calls Stephen Barker spoke on are classified in the Healthcare sector.
“Two questions again about Zasso and UC and Memrilo. Regarding ZASO in UC, can you clarify if it was the high dose or the low dose which showed indications of efficacy?”
“So my first one is regarding estimates for overporexone and risvetide in the current year. I understand that you have producers for both drugs in August, and do you have any revenues baked into your current year estimates?”
Jefferies
Analyst
Transcript header (unverified)
Drug Manufacturers - Specialty & Generic · Healthcare
